ImmunityBio Announces Comprehensive U.S. Patents Covering Combination of ANKTIVA with BCG for Cancer Treatment, with Terms Through 2035

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to ImmunityBio Announces Comprehensive U.S. Patents Covering Combination of ANKTIVA with BCG for Cancer Treatment, with Terms Through 2035
(NASDAQ: IBRX) Delayed: 7.45 +0.23 (3.19%)
Previous Close $7.22    52 Week High $ 
Open $7.05    52 Week Low $ 
Day High $7.54    P/E N/A 
Day Low $7.00    EPS $ 
Volume 5,698,882